Predictors of primary non-response and drug durability for adalimumab and infliximab in pediatric inflammatory bowel disease
This study evaluates predictors of primary non-response and long-term durability in children with IBD.
Source: Gastroenterology - Category: Gastroenterology Authors: Nicole Davidson, Grant Morris, Molly Wright, Guy Brock, Brendan Boyle, Jennifer Dotson, Hilary Michel, Ross Maltz Source Type: research
More News: Children | Gastroenterology | Grants | Humira | Inflammatory Bowel Disease | Pediatrics | Remicade | Study